Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Aug 1;8(8):e2525789.
doi: 10.1001/jamanetworkopen.2025.25789.

Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical Trial

Affiliations
Observational Study

Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical Trial

Gregory E Tasian et al. JAMA Netw Open. .

Abstract

Importance: Most children and adolescents with kidney and ureteral stones are treated with ureteroscopy, despite the uncertainty and equal weight of guideline recommendations for ureteroscopy or shockwave lithotripsy.

Objective: To compare stone clearance and patient-reported outcomes among children and adolescents after ureteroscopy or shockwave lithotripsy.

Design, setting, and participants: This nonrandomized clinical trial enrolled patients between March 16, 2020, and July 31, 2023, at 31 medical centers in the US and Canada. Patients aged 8 to 21 years with kidney stones, ureteral stones, or both were included. Follow-up was completed on October 15, 2023.

Interventions: Ureteroscopy or shockwave lithotripsy.

Main outcomes and measures: The primary outcome was stone clearance assessed by standardized ultrasonography 6 (±2) weeks after surgery. Using inverse probability weighting and random intercepts for site, stone clearance was evaluated per kidney or ureter using logistic regression and estimated stone clearance rates were generated for each procedure.

Results: This study included 1142 patients (690 females [60.4%]), with a median age of 15.6 years (IQR, 12.6-17.3 years). In terms of race and ethnicity, 41 patients (3.6%) were Black, 130 (11.4%) were Hispanic, and 884 (77.4%) were White. A total of 124 urologists treated 1069 and 197 kidneys or ureters with ureteroscopy and shockwave lithotripsy (n = 953 and n = 189 patients), respectively, with a median stone size of 6.0 mm (IQR, 4.0-9.0 mm). Ureteral stents were placed at time of index surgery for 841 procedures for 767 patients (80.4%) receiving ureteroscopy and for 6 procedures for 5 patients (2.6%) receiving shockwave lithotripsy. Stone clearance occurred in 474 patients who underwent ureteroscopy (71.2% [95% CI, 63.8%-78.5%]) and in 105 patients who underwent shockwave lithotripsy (67.5% [95% CI, 61.0%-74.1%]), a difference that was not statistically significant (risk difference, 3.6% [95% CI, -6.2% to 13.5%]). Compared with shockwave lithotripsy, ureteroscopy resulted in greater pain interference (T-score difference, 5.0 [95% CI, 2.3-7.8]) and urinary symptoms (symptom score difference, 3.9 [95% CI, 1.2-6.7]) 1 week after surgery. Patients who had ureteroscopy missed more school (risk difference, 21.3% [95% CI, 9.7%-32.8%]) and caregivers missed more work (risk difference, 23.0% [95% CI, 11.0%-35.0%]) in the week after surgery.

Conclusions and relevance: In this study of 1142 children and adolescents with kidney and ureteral stones, there was no clinically meaningful difference in stone clearance with ureteroscopy vs shockwave lithotripsy. Shockwave lithotripsy was associated with better patient-reported outcomes. These findings raise questions about the preference for ureteroscopy in practice.

Trial registration: ClinicalTrials.gov Identifier: NCT04285658.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Tasian reported receiving grants from the Patient-Centered Outcomes Research Institute (PCORI) during the conduct of the study. In addition, Dr Tasian reported serving on scientific advisory boards of Alnylam Pharmaceuticals and Novo Nordisk outside the submitted work. Dr Chu reported receiving grants from PCORI and the National Institutes of Health (NIH) during the conduct of the study. Dr C. P. Nelson reported receiving grants from PCORI during the conduct of the study. Dr DeFoor reported investing in American Kidney Stone Management outside the submitted work. Dr Back reported receiving grants from Bracco Diagnostics and contracting with Philips Ultrasound outside the submitted work. Dr Ellison reported receiving grants from PCORI during the conduct of the study and receiving personal fees from UpToDate outside the submitted work. Dr Rove reported receiving grants from Sumitomo Pharma and acting as the site principal investigator at Children’s Hospital Colorado for the KANGUROO study (NCT05491525) outside the submitted work. Dr Tong reported receiving personal fees from Novo Nordisk outside the submitted work. Dr Denburg reported receiving grants from PCORI during the conduct of the study and serving on the Kidney Disease Improving Global Outcomes Executive Committee and as Associate Editor for the Journal of the American Society of Nephrology outside the submitted work. Dr Ellison reported receiving grants from PCORI during the conduct of the study and receiving personal fees from UpToDate outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Flow Diagram of Patients Who Underwent Ureteroscopy or Shockwave Lithotripsy for Kidney Stone Removal
aParticipants did not receive ureteroscopy or shockwave lithotripsy. bParticipants who withdrew but allowed data collection remained in the analysis cohort. cStone clearance evaluated at the kidney level. dTreatment group allocation and patient-reported outcome (PRO) evaluation are at the patient level. eUltrasonography studies either reported no stone present or had measured stone size.

References

    1. Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol. 2010;184(3):1100-1104. doi: 10.1016/j.juro.2010.05.018 - DOI - PubMed
    1. Tasian GE, Ross ME, Song L, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016;11(3):488-496. doi: 10.2215/CJN.07610715 - DOI - PMC - PubMed
    1. Routh JC, Graham DA, Nelson CP. Trends in imaging and surgical management of pediatric urolithiasis at American pediatric hospitals. J Urol. 2010;184(4)(suppl):1816-1822. doi: 10.1016/j.juro.2010.03.117 - DOI - PubMed
    1. Harper JD, Desai AC, Maalouf NM, et al. Risk factors for increased stent-associated symptoms following ureteroscopy for urinary stones: results from STENTS. J Urol. 2023;209(5):971-980. doi: 10.1097/JU.0000000000003183 - DOI - PMC - PubMed
    1. Tasian GE, Maltenfort MG, Rove K, et al. Ureteral stent placement prior to definitive stone treatment is associated with higher postoperative emergency department visits and opioid prescriptions for youth having ureteroscopy or shock wave lithotripsy. J Urol. 2023;209(6):1194-1201. doi: 10.1097/JU.0000000000003389 - DOI - PubMed

Associated data